LFCR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lifecore Biomedical Inc (LFCR) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. While the company has shown revenue growth, its declining net income and EPS, coupled with neutral trading trends and lack of significant positive catalysts, suggest that it is better to hold off on purchasing this stock right now.
The MACD is positive and expanding, indicating a slight bullish momentum. RSI is neutral at 53.599, and moving averages are converging, showing no clear trend. Key resistance levels are at 7.419 and 7.569, with support at 6.934 and 6.784. Overall, the technical indicators suggest a neutral to slightly positive outlook.
Revenue increased by 25.92% YoY in Q1 2026, and gross margin improved by 14.81% YoY.
Net income dropped by 32.76% YoY, and EPS fell by 45.28% YoY. No significant hedge fund or insider activity, no recent news, and no recent congress trading data.
In Q1 2026, revenue increased to $31.1M (up 25.92% YoY), but net income dropped to -$10.91M (down 32.76% YoY), and EPS decreased to -0.29 (down 45.28% YoY). Gross margin improved to 25.04% (up 14.81% YoY).
No recent data on analyst ratings or price target changes.
